During her visit, the Minister for Social Affairs, Health and Women's Rights was able to learn more about the progress made by Pixium Vision in the development of its vision restoration systems
Paris, 22 April 2015 - Pixium Vision (FR0011950641 - PIX), announced that it received the visit from Marisol Touraine, Minister for Social Affairs, Health and Women's Rights.
Pixium Vision is currently conducting clinical trials in the development of IRIS®, its first vision restoration system. This system is designed for patients blinded by Retinitis Pigmentosa (RP), an irreversible condition for which there is no current cure, affecting more than one and a half million people worldwide.
During her visit, Marisol Touraine met one of the patients using the IRIS® system. Having become blind more than twenty years ago, he is now able to move around more independently and distinguish shapes and objects.
Marisol Touraine welcomed the innovation delivered by the IRIS® system: a significant step forward and an innovative technology, meeting substantial social and clinical needs for patients suffering from this highly debilitating condition.
Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.
Pour consulter le fichier PDF en intégralité, cliquez ici.
|PIXIUM VISION||Euronext Paris||3.09||0.32%||6 270|